MedPath

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

Conditions
Escherichia Coli
Antibiotic Resistance
Extended-spectrum Betalactamase
Enterobacteriaceae
Registration Number
NCT02367339
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Detailed Description

Prospective epidemiological study with voluntary non-medical staff member (i.e. nurses and nursing assistants) and medical staff in two French ICUs.

Assessment of self-reported risk factors for MDR-bacteria colonization. Self-performed rectal swab with isolation of ESBL-producting Enterobacteriaceae, identification of bacterial species and antibiotic suspectibilities.

Characterization of Escherichia coli ESBL.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • volunteers
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Digestive tract colonization by ESBLat day 1

Digestive tract colonization by ESBL-producing Enterobacteriaceae on 1 faeces sample

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

CHU de Clermont-Ferrand
🇫🇷Clermont-Ferrand, France
Patrick LACARIN
Contact
04 73 75 11 95
placarin@chu-clermontferrand.fr
Julien PASCAL
Principal Investigator
Bertrand SOUWEINE
Sub Investigator
Jean-Michel CONSTANTIN
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.